Wells Fargo Portfolio holdings
Wells Fargo & Company, founded in 1852 by Henry Wells and William Fargo, is a major American financial institution headquartered in San Francisco, California, known for its extensive retail banking network and historical roots in the American West. Offering a wide range of services—including consumer banking, mortgages, wealth management, and commercial finance—it manages trillions in assets and serves millions of customers through thousands of branches and ATMs across the U.S. Despite its prominence, Wells Fargo faced significant scrutiny following a 2016 scandal involving millions of unauthorized accounts, leading to leadership changes and regulatory penalties, though it has since focused on rebuilding trust and enhancing digital banking capabilities. With a legacy tied to stagecoaches and a modern focus on diversified financial services, Wells Fargo remains a key player in the U.S. banking sector.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$506M |
| 2 |
Microsoft
MSFT
|
+$336M |
| 3 |
Amazon
AMZN
|
+$287M |
| 4 |
Apple
AAPL
|
+$269M |
| 5 |
Meta Platforms (Facebook)
META
|
+$233M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Air Products & Chemicals
APD
|
+$425M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$334M |
| 3 |
United Parcel Service
UPS
|
+$148M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$128M |
| 5 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.28% |
| 2 | Financials | 7.45% |
| 3 | Healthcare | 7.23% |
| 4 | Industrials | 6.23% |
| 5 | Consumer Discretionary | 5.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5101
Arcos Dorados Holdings
ARCO
$1.74B
| $51.8K | ﹤0.01% |
5,751
-3,644
| -39% | -$37.5K |
|
|
ELEV
5102
DELISTED
Elevation Oncology
ELEV
| $51.7K | ﹤0.01% |
19,146
+18,901
| +7,715% | +$71.2K |
|
5103
Fidelity Enhanced International ETF
FENI
$11.3B
| $51.7K | ﹤0.01% |
1,823
-139
| -7% | -$3.96K |
|
|
CMBT
5104
CMB.TECH NV
CMBT
$4.73B
| $51.4K | ﹤0.01% |
3,123
| – | – |
|
5105
Century Therapeutics
IPSC
$361M
| $51.4K | ﹤0.01% |
20,158
+11,895
| +144% | +$37.6K |
|
5106
Cardiff Oncology
CRDF
$77.2M
| $51.1K | ﹤0.01% |
23,019
+15,194
| +194% | +$57.3K |
|
5107
Harvard Bioscience
HBIO
$29.2M
| $50.8K | ﹤0.01% |
1,783
+453
| +34% | +$15.9K |
|
5108
Nautilus Biotechnolgy
NAUT
$115M
| $50.8K | ﹤0.01% |
21,706
+3,565
| +20% | +$9.31K |
|
5109
Rallybio
RLYB
$85.8M
| $50.7K | ﹤0.01% |
4,725
+1,473
| +45% | +$20K |
|
5110
Baytex Energy
BTE
$2.92B
| $50.5K | ﹤0.01% |
14,591
-1,841
| -11% | -$6.59K |
|
5111
Annovis Bio
ANVS
$80M
| $50.4K | ﹤0.01% |
8,747
-54
| -0.6% | -$438 |
|
5112
Rigel Pharmaceuticals
RIGL
$750M
| $49.7K | ﹤0.01% |
6,041
+751
| +14% | +$7.86K |
|
5113
Acumen Pharmaceuticals
ABOS
$176M
| $49.4K | ﹤0.01% |
20,431
+19,223
| +1,591% | +$61.2K |
|
5114
1stdibs.com
DIBS
$171M
| $49.4K | ﹤0.01% |
10,995
+10,314
| +1,515% | +$56.3K |
|
5115
CPI Card Group
PMTS
$320M
| $49.4K | ﹤0.01% |
1,811
+325
| +22% | +$7.34K |
|
5116
Intuitive Machines
LUNR
$2.63B
| $49.3K | ﹤0.01% |
14,940
+12,059
| +419% | +$59.9K |
|
5117
Ispire Technology
ISPR
$98.2M
| $49.2K | ﹤0.01% |
6,151
+1,036
| +20% | +$6.68K |
|
5118
Viant Technology
DSP
$265M
| $49.1K | ﹤0.01% |
4,978
+528
| +12% | +$4.92K |
|
5119
The Joint Corp
JYNT
$119M
| $49K | ﹤0.01% |
3,485
-777
| -18% | -$11.1K |
|
5120
Q32 Bio
QTTB
$464M
| $49K | ﹤0.01% |
2,727
+2,648
| +3,352% | +$63.4K |
|
|
SBT
5121
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $48.9K | ﹤0.01% |
9,347
+1,699
| +22% | +$8.37K |
|
5122
Sasol
SSL
$7.1B
| $48.7K | ﹤0.01% |
6,396
+1,025
| +19% | +$7.58K |
|
5123
uniQure
QURE
$3.22B
| $48.6K | ﹤0.01% |
10,856
-351
| -3% | -$1.71K |
|
5124
Quest Resource Holding
QRHC
$31.6M
| $48.6K | ﹤0.01% |
5,523
+5,413
| +4,921% | +$49.9K |
|
5125
iShares iBonds 2028 Term High Yield and Income ETF
IBHH
$457M
| $48.6K | ﹤0.01% |
2,100
| – | – |
|
Similar funds
Wells Fargo's Q2 2024 Portfolio in Review
As of Q2 2024, Wells Fargo held 7,784 positions worth $412B, down 0.64% from $415B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Wells Fargo's Q2 2024 filing shows 386 new, 3,308 increased, 2,367 reduced and 944 closed positions. Its largest new stake was NextEra Energy 7.299% Corporate Units: 1,487,927 shares worth $73.6M. The largest sale was Air Products & Chemicals, an estimated $425M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
- Wells Fargo's largest Q2 2024 buy was NextEra Energy 7.299% Corporate Units: 1,487,927 shares worth $73.6M.
- Wells Fargo added most to State Street SPDR S&P 500 ETF Trust in Q2 2024, an estimated $506M increase.
- Wells Fargo's biggest Q2 2024 reduction was Air Products & Chemicals, cutting an estimated $425M.
- Wells Fargo fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $88.9M.
- Wells Fargo's ten largest holdings make up 19% of its $412B portfolio in Q2 2024.
- Wells Fargo opened 386 new positions and closed 944 in Q2 2024.
- Wells Fargo's portfolio value fell 0.64% quarter-over-quarter to $412B.
Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.